| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T784 |
0-4 |
G_3;PG_10;PR:000003622 |
denotes |
ACE2 |
| T785 |
6-14 |
SP_7 |
denotes |
COVID-19 |
| T786 |
20-34 |
UBERON:0004535 |
denotes |
Cardiovascular |
| T31987 |
40-50 |
UBERON:0002349 |
denotes |
e
Several |
| T787 |
69-77 |
SP_7 |
denotes |
COVID-19 |
| T45 |
69-77 |
SP_7 |
denotes |
COVID-19 |
| T788 |
97-104 |
UBERON:0000948 |
denotes |
cardiac |
| T46 |
97-104 |
UBERON:0000948 |
denotes |
cardiac |
| T2470 |
147-154 |
UBERON:0000948 |
denotes |
ized pa |
| T789 |
176-184 |
SP_7 |
denotes |
COVID-19 |
| T74256 |
196-201 |
GO:0016265 |
denotes |
tient |
| T790 |
239-257 |
PR:000005897 |
denotes |
C-reactive protein |
| T791 |
319-329 |
UBERON:0002349 |
denotes |
myocardial |
| T792 |
405-412 |
UBERON:0000948 |
denotes |
cardiac |
| T20349 |
430-444 |
UBERON:0004535 |
denotes |
e imagining−ve |
| T79848 |
479-490 |
NCBITaxon:11118 |
denotes |
ystolic dys |
| T82178 |
507-515 |
SP_7 |
denotes |
ding as |
| T793 |
544-554 |
UBERON:0002349 |
denotes |
myocardial |
| T794 |
580-587 |
UBERON:0000948 |
denotes |
cardiac |
| T26035 |
610-614 |
G_3;PG_10;PR:000003622 |
denotes |
of |
| T10049 |
615-625 |
GO:0065007 |
denotes |
bstructive |
| T795 |
626-634 |
UBERON:0001621 |
denotes |
coronary |
| T65218 |
674-683 |
CHEBI:35222;CHEBI:35222 |
denotes |
patients |
| T796 |
688-696 |
SP_7 |
denotes |
COVID-19 |
| T797 |
742-752 |
UBERON:0002349 |
denotes |
myocardial |
| T55523 |
752-760 |
SP_7 |
denotes |
injury, |
| T53933 |
804-812 |
SP_7 |
denotes |
(61). O |
| T49807 |
817-824 |
SP_7 |
denotes |
observ |
| T798 |
848-855 |
UBERON:0000948 |
denotes |
cardiac |
| T79663 |
856-870 |
DG_37;PR:000036009 |
denotes |
injury were fo |
| T799 |
897-902 |
GO:0016265 |
denotes |
death |
| T15361 |
912-920 |
SP_7 |
denotes |
time of |
| T52890 |
1030-1038 |
CHEBI:6541;CHEBI:6541 |
denotes |
affecte |
| T87551 |
1071-1079 |
SP_7 |
denotes |
ble to e |
| T34732 |
1108-1116 |
SP_7 |
denotes |
ation of |
| T800 |
1134-1148 |
UBERON:0004535 |
denotes |
cardiovascular |
| T23219 |
1174-1184 |
GO:0040011 |
denotes |
is novel c |
| T801 |
1183-1194 |
NCBITaxon:11118 |
denotes |
coronavirus |
| T802 |
1211-1219 |
SP_7 |
denotes |
COVID-19 |
| T76836 |
1213-1221 |
SP_7 |
denotes |
VID-19, |
| T803 |
1314-1318 |
G_3;PG_10;PR:000003622 |
denotes |
ACE2 |
| T804 |
1319-1329 |
GO:0065007 |
denotes |
regulation |
| T3029 |
1359-1370 |
NCBITaxon:11118 |
denotes |
the impact |
| T36086 |
1372-1380 |
SP_7 |
denotes |
f ACE in |
| T805 |
1378-1387 |
CHEBI:35222;CHEBI:35222 |
denotes |
inhibitor |
| T806 |
1453-1461 |
SP_7 |
denotes |
COVID-19 |
| T82622 |
1500-1510 |
SP_7 |
denotes |
With COVI |
| T807 |
1506-1514 |
SP_7 |
denotes |
COVID-19 |
| T808 |
1519-1526 |
SP_7 |
denotes |
COVID19 |
| T40928 |
1552-1562 |
CHEBI:35222;CHEBI:35222 |
denotes |
tors, Angi |
| T809 |
1558-1572 |
DG_37;PR:000036009 |
denotes |
Angiotensin II |
| T14768 |
1605-1619 |
UBERON:0004535 |
denotes |
erity of COVID |
| T810 |
1614-1622 |
SP_7 |
denotes |
COVID-19 |
| T50691 |
1632-1640 |
SP_7 |
denotes |
E], NCT0 |
| T811 |
1729-1737 |
CHEBI:6541;CHEBI:6541 |
denotes |
losartan |
| T93421 |
1737-1745 |
SP_7 |
denotes |
among p |
| T67192 |
1760-1765 |
SP_6;NCBITaxon:9606;PG_10 |
denotes |
lized |
| T67994 |
1766-1797 |
PG_10;PR:000003622 |
denotes |
with COVID-19 (Losartan for Pat |
| T812 |
1771-1779 |
SP_7 |
denotes |
COVID-19 |
| T813 |
1808-1816 |
SP_7 |
denotes |
COVID-19 |
| T78338 |
1841-1849 |
SP_7 |
denotes |
n; NCT04 |
| T814 |
1875-1885 |
GO:0040011 |
denotes |
ambulatory |
| T815 |
1914-1922 |
SP_7 |
denotes |
COVID-19 |
| T89352 |
1946-1956 |
CHEBI:35222;CHEBI:35222 |
denotes |
zation; NC |
| T71976 |
1974-1982 |
SP_7 |
denotes |
r studie |
| T44016 |
1984-1988 |
G_3;PG_10;PR:000003622 |
denotes |
have |
| T47722 |
1993-2003 |
SP_7 |
denotes |
launched |
| T88225 |
2004-2012 |
SP_10 |
denotes |
o evalua |
| T816 |
2062-2073 |
NCBITaxon:11118 |
denotes |
Coronavirus |
| T20549 |
2065-2075 |
SP_7 |
denotes |
onavirus [ |
| T817 |
2075-2083 |
SP_7 |
denotes |
COVID-19 |
| T74305 |
2127-2140 |
NCBITaxon:11118 |
denotes |
330300) or wi |
| T20522 |
2168-2172 |
G_3;PG_10;PR:000003622 |
denotes |
ARBs |
| T818 |
2203-2213 |
SP_7 |
denotes |
SARS-CoV-2 |
| T819 |
2255-2265 |
CHEBI:35222;CHEBI:35222 |
denotes |
inhibitors |
| T10417 |
2278-2285 |
NCBITaxon:10239 |
denotes |
cal out |
| T820 |
2308-2322 |
UBERON:0004535 |
denotes |
cardiovascular |
| T821 |
2335-2343 |
SP_7 |
denotes |
COVID-19 |
| T82275 |
2368-2377 |
SP_7 |
denotes |
g pilot s |
| T54073 |
2387-2391 |
G_3;PG_10;PR:000003622 |
denotes |
sing |
| T822 |
2441-2449 |
SP_7 |
denotes |
COVID-19 |
| T59849 |
2453-2461 |
SP_10 |
denotes |
combinan |
| T823 |
2463-2468 |
SP_6;NCBITaxon:9606;PG_10 |
denotes |
Human |
| T87907 |
2468-2478 |
SP_7 |
denotes |
Angiotens |
| T824 |
2469-2500 |
PG_10;PR:000003622 |
denotes |
Angiotensin-converting Enzyme 2 |
| T87618 |
2488-2492 |
G_3;PG_10;PR:000003622 |
denotes |
ing |
| T56047 |
2531-2538 |
GO:0009986 |
denotes |
tients |
| T825 |
2543-2551 |
SP_7 |
denotes |
COVID-19 |
| T52387 |
2555-2564 |
PG_1 |
denotes |
T04287686 |
| T22150 |
2574-2578 |
G_3;PG_10;PR:000003622 |
denotes |
ly, |
| T49602 |
2598-2603 |
NCBITaxon:10239 |
denotes |
suppo |
| T826 |
2647-2657 |
CHEBI:35222;CHEBI:35222 |
denotes |
inhibitors |
| T68685 |
2664-2669 |
NCBITaxon:10239 |
denotes |
ients |
| T827 |
2675-2683 |
SP_7 |
denotes |
COVID-19 |
